+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Eubiotics Market Size, Share & Industry Trends Analysis Report By Product, By Application, By Form, By End-use, By Regional Outlook and Forecast, 2022 - 2028

  • PDF Icon

    Report

  • 249 Pages
  • May 2022
  • Region: Global
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 5615382
The Global Eubiotics Market size is expected to reach $7.2 billion by 2028, rising at a market growth of 7.6% CAGR during the forecast period.



In current farm systems, good gut health is essential to the production and welfare of farm animals. As a result, eubiotics enhance animal performance and welfare. The eubiotics help to achieve equilibrium by boosting the prevalence of beneficial gastrointestinal flora, increasing food absorption, and enhancing gut performance.

Eubiotics are produced and delivered by feed mills, pre-mixers, and specialized wholesalers. Eubiotics manufacturers sell their products directly to clients or through integrated feed producers. Fermentation and chemical synthesis are used to make eubiotics such as organic acids. For animal feed purposes such as silage and feed additives, the chemical synthesis procedure is typically preferred.

Raw material accessibility, agro-climatic circumstances, regional authorities, and other factors all influence the pricing of Eubiotics. Due to the presence of price-sensitive clients, manufacturers compete based on competitive pricing. To achieve a competitive advantage in the market, firms are focusing on process innovation and low-cost raw material procurement. Furthermore, the rapid rise of end-use applications such as feed and pharmaceuticals, as well as growing eubiotics production, which is expected to close the supply-demand imbalance, is expected to moderately raise prices throughout the forecast period.

Prebiotics and probiotics play a key role in the value chain of the nutraceuticals industry due to the technological advancements, low-cost labor, and ample raw material availability due to upscale production, developing economies like India and China are well-positioned in the market. As a result, key firms in developing economies are constructing an optimized process and a reliable supply chain for cost-effective product manufacture, allowing them to provide items at reduced rates.

COVID-19 Impact Analysis


The COVID-19 pandemic has had a minor influence on the eubiotics sector. The overall impact on the industry is mixed, since corporations have incurred financial losses as a result of broad mobility limitations in important markets. However, the pandemic has raised awareness about the negative consequences of antibiotics in food animals, positively impacting the expansion of the eubiotic sector. COVID-19 caused a worldwide shutdown of factories, production and manufacturing centers, restaurants, hotels, and other businesses. This resulted in a manpower shortage, a supply chain disruption, and a reduction in the supply of raw materials and other ingredients.

Market Growth Factors


The Portrayal of Pets and the Increasing Pet Ownership Rate


In recent years, pet humanization has become a catchphrase in the public media around the world. In the pet food market, the shift from owning a pet to pet parenthood has been a huge and important development, particularly in developed countries. More than one-third of households in developed countries have a pet. Consumers' propensity to spend more on pet food is influenced by the growing attachment between pet owners and their pets. Pet owners' main objectives are increasingly becoming their pets' optimal health. They attempt to keep their pets healthy by feeding them a nutrient-dense, easily digestible diet.

An increase in the number of chicken farms and spending on pets


Compared to other cattle, it requires less investment. Starting a chicken poultry farm just costs a small amount. Agricultural laborer’s and small farmers can now start farming on a small scale. The chicken begins to lay eggs after 8 to 10 weeks, but broilers can be sold after 6 weeks, at a weight of 1.25 kg. This provides an immediate return on investment. In 8 to 10 weeks, chickens begin laying eggs, and broilers can be sold for meat in 6 to 10 weeks. Because the time between generations is so brief, productivity can be dramatically boosted in a short amount of time. Broilers use a small amount of feed while producing the greatest amount of food for humans.

Marketing Restraining Factor:


Uncertainty in regulations limits international trade


Animal food must be safe to eat and manufactured in hygienic conditions, as per the Federal Food, Drug, and Cosmetic Act of 1938. (FFDCA). The foods must have no dangerous ingredients and be labeled as accurately as possible. For pet food makers in the United States, the Food Safety Modernization Act of 2010 (FSMA) established certification, sterilization, cleanliness, and ingredient labeling standards. The animal feed business, in contrast to the Asia Pacific and South American regions, is governed by strict government controls. Preservatives, ethoxyquin, and food colorings are all regulated differently in different nations when it comes to pet food components.

Product Type Outlook


Based on Product, the market is segmented into Probiotics, Organic Acids, Phytogenic, Prebiotics, and Enzymes. The organic acids segment garnered a significant revenue share in the Eubiotic market in 2021. Acidifiers are natural organic acids and ions that have received a lot of attention as animal feed supplements in the manufacture of environmentally friendly aquaculture products. Acidifiers in fish diets have shown to have good potential, and there is enough information to recommend aqua feed makers to explore utilizing them. Organic acids in food have a eubiotic influence on the proliferation of indigenous lactic acid bacteria, which are important in the activation of the immunological response to illnesses.

Application Outlook


Based on Application, the market is segmented into Gut Health, Immunity, Yield, and Others. The gut health segment procured the largest revenue share in the Eubiotic market in 2021. It is because eubiotics can help to enhance gut health, allowing for a fair reduction in antibiotic usage. As a result, it appears that eubiotics can not only replace antibiotics but also complement them to provide extra benefits. Maintaining a diversified and balanced population of gut microbes while reducing the prevalence of potentially harmful bacteria is critical for gut health, growth, and lifetime function.

Form Outlook


Based on Form, the market is segmented into Solid and Liquid. The liquid segment registered a significant revenue share in the Eubiotic market in 2021. Due to the additives such as liquid eubiotics are utilized in the feed industry due to simple manufacturing procedures and low production costs. Due to their ease of feeding and compatibility, liquid eubiotics are mostly employed for pig and aquaculture nutrition. Pigs are typically provided liquid feed, which helps to increase growth and feed conversion ratio, which generates demand for liquid eubiotics products.

End-use Outlook


Based on End-use, the market is segmented into Poultry Feed, Swine Feed, Cattle Feed, Aquatic Feed, and Others. The poultry feed segment garnered the highest revenue share in the Eubiotic market in 2021. Antibiotic residues have been discovered in meat, posing a risk to human health. Antibiotics have become a source of public debate due to their negative health effects, causing countries to prohibit their use. Disease pandemic such as swine flu, avian flu, and different foot and mouth illnesses are a worry for livestock farmers. Farmers are turning to feasible alternatives such as eubiotics in response to growing concerns about meat quality and safety, as well as a regulatory environment that discourages the use of antibiotics.

Regional Outlook


Based on Regions, the market is segmented into North America, Europe, Asia Pacific, and Latin America, Middle East & Africa. The Europe segment acquired the largest revenue share in the Eubiotic market in 2021. This can be due to rising meat consumption along with increased cattle output. Meat consumption has increased dramatically in recent years in countries such as Italy, France, and Germany, prompting producers to seek out high-quality, disease-free animal products. The European Union (EU) produces the third most beef in the world. This benefits Europe's economy, rural development, social life, culture, and cuisine. The industry's diversity of breeds, animal such as cows, bulls, steers, heifers, and farming practices intense, extensive on permanent or temporary pastures, mixed, breeders, feeders is both a strength and a problem.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Koninklijke DSM N.V., Novozymes A/S, BASF SE, DuPont de Nemours, Inc., Chr. Hansen holding A/S, Lallemand, Inc., Lesaffre Group, Kemin Industries, Inc., Cargill Corporation, and Calpis Co., Ltd.
  • Oct-2021: BASF extended its partnership with Cargill, a global food enterprise. Through this partnership, the companies is expected to establish and manufacture enzyme solutions and products for the animal feed market.
  • Jul-2021: Royal DSM took over Midori USA, a biotechnology business developing breakthrough targeted eubiotics. Through this acquisition, Midori’s platform is expected to be greatly cooperative with DSM’s bioscience abilities and actual eubiotics offering.
  • Jun-2021: The DSM - Novozymes Feed Enzymes association launched ProAct 360, a second-generation protease. The solution provides an extra accordant enhancement in growth accomplishment, along with enhanced matrix values for main amino acids and quick response.
  • Apr-2021: Kemin Industries unveiled Tegravia and Paradigmox Green, two new products. The Tegravia offers a usable fiber for the pet food market in South America, especially in Brazil whereas, Paradigmox Green is an antioxidant solution for the natural livestock production enterprise in the EMENA region.
  • Feb-2021: Lallemand came into a partnership with Poultry Sense, which provides enhanced technology for poultry farmers. Through this partnership, the companies aimed to enhance the credibility and dependability of data obtained from corporate farm trials. Moreover, data is expected to deliver Lallemand with an extraordinarily competitive market while delivering consumer with precise data that is expected to assist more assurance in new choices.
  • Dec-2020: Royal DSM signed an agreement with VALIO, Finland’s largest global dairy cooperative enterprise. Through this agreement, the companies aimed to substantially decrease the carbon trace of dairy management in Finland. Additionally, VALIO focus to build its dairy value chain carbon-impartial by 2035.
  • Oct-2020: Royal DSM completed the acquisition of Erber Group, the global leader in the field of food and feed safety. Through this acquisition, the company aimed to reinforce DSM’s recognition and expertise as a dominant supplier of animal nutrition and health solutions for farm sustainability and efficiency, with prominence on emissions decrease, feed utilization adaptability, and improved usage of land and water.
  • Jun-2020: Cargill along with China Animal Health and Food Safety Alliance introduced Sun Valley, a Raised Without Antibiotics chicken product. Under this launch, utilizing blockchain technology, the three latest products concentrate on clarity and food safety around the complete farm-to-fork supply chain.
  • Jun-2020: DSM Animal Nutrition and Health came into a partnership with North Carolina State University, a dominant public research university. Through this partnership, the companies aimed to research accurate nutrition, gut health, and data forced animal health judgment for feed, livestock, and pet animals. Additionally, the partnership is expected to inquire into the issue of farmed fish, pet animals, cattle, and various small cogitative animals.
  • Sep-2018: DSM along with Novozyms unveiled Balancius, a major discovery in poultry nutrition. The solution extensively boosts feed digestibility and effectiveness in broilers.
  • Mar-2018: Phileo Lesaffre Animal Care formed a partnership with Diana Pet Food, the global leader and pioneer of high-value solutions improving pets' well-being and owners' satisfaction. Together, the companies aimed to provide a stable performance record in providing high-performance health and nutrition solutions to the commerce, to better distribute consumers to increase the worth given to the pet food market.
  • Mar-2018: Calpis received a European Commission approval for the probiotic Calsporin for suckling piglets, cows, and dogs' feed. The probiotic Calsporin carries feasible spores of Bacillus subtilis C-3102 and is with a quantity of 1.0 x 1010 CFU / gram is extremely concentrated. Additionally, sturdy spores of the Bacillus strain combat high temperatures during supplement and feed procedures.

Scope of the Study


Market Segments Covered in the Report:


By Product

  • Probiotics
  • Organic Acids
  • Phytogenic
  • Prebiotics
  • Enzymes

By Application

  • Gut Health
  • Immunity
  • Yield
  • Others

By Form

  • Solid
  • Liquid

By End-use

  • Poultry Feed
  • Swine Feed
  • Cattle Feed
  • Aquatic Feed
  • Others

By Geography

  • North America
  • US
  • Canada
  • Mexico
  • Rest of North America
  • Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Malaysia
  • Rest of Asia Pacific
  • LAMEA
  • Brazil
  • Argentina
  • Egypt
  • Tanzania
  • South Africa
  • Nigeria
  • Rest of LAMEA

Key Market Players


List of Companies Profiled in the Report:

  • Koninklijke DSM N.V.
  • Novozymes A/S
  • BASF SE
  • DuPont de Nemours, Inc.
  • Chr. Hansen holding A/S
  • Lallemand, Inc.
  • Lesaffre Group
  • Kemin Industries, Inc.
  • Cargill Corporation
  • Calpis Co., Ltd.

Unique Offerings from KBV Research

  • Exhaustive coverage
  • The highest number of market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Eubiotics Market, by Product
1.4.2 Global Eubiotics Market, by Application
1.4.3 Global Eubiotics Market, by Form
1.4.4 Global Eubiotics Market, by End-use
1.4.5 Global Eubiotics Market, by Geography
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Strategies Deployed in Eubiotics Market
Chapter 4. Global Eubiotics Market by Product
4.1 Global Probiotics Market by Region
4.2 Global Organic Acids Market by Region
4.3 Global Phytogenic Market by Region
4.4 Global Prebiotics Market by Region
4.5 Global Enzymes Market by Region
Chapter 5. Global Eubiotics Market by Application
5.1 Global Gut Health Market by Region
5.2 Global Immunity Market by Region
5.3 Global Yield Market by Region
5.4 Global Others Market by Region
Chapter 6. Global Eubiotics Market by Form
6.1 Global Solid Market by Region
6.2 Global Liquid Market by Region
Chapter 7. Global Eubiotics Market by End-use
7.1 Global Poultry Feed Market by Region
7.2 Global Swine Feed Market by Region
7.3 Global Cattle Feed Market by Region
7.4 Global Aquatic Feed Market by Region
7.5 Global Others Market by Region
Chapter 8. Global Eubiotics Market by Region
8.1 North America Eubiotics Market
8.1.1 North America Eubiotics Market by Product
8.1.1.1 North America Probiotics Market by Country
8.1.1.2 North America Organic Acids Market by Country
8.1.1.3 North America Phytogenic Market by Country
8.1.1.4 North America Prebiotics Market by Country
8.1.1.5 North America Enzymes Market by Country
8.1.2 North America Eubiotics Market by Application
8.1.2.1 North America Gut Health Market by Country
8.1.2.2 North America Immunity Market by Country
8.1.2.3 North America Yield Market by Country
8.1.2.4 North America Others Market by Country
8.1.3 North America Eubiotics Market by Form
8.1.3.1 North America Solid Market by Country
8.1.3.2 North America Liquid Market by Country
8.1.4 North America Eubiotics Market by End-use
8.1.4.1 North America Poultry Feed Market by Country
8.1.4.2 North America Swine Feed Market by Country
8.1.4.3 North America Cattle Feed Market by Country
8.1.4.4 North America Aquatic Feed Market by Country
8.1.4.5 North America Others Market by Country
8.1.5 North America Eubiotics Market by Country
8.1.5.1 US Eubiotics Market
8.1.5.1.1 US Eubiotics Market by Product
8.1.5.1.2 US Eubiotics Market by Application
8.1.5.1.3 US Eubiotics Market by Form
8.1.5.1.4 US Eubiotics Market by End-use
8.1.5.2 Canada Eubiotics Market
8.1.5.2.1 Canada Eubiotics Market by Product
8.1.5.2.2 Canada Eubiotics Market by Application
8.1.5.2.3 Canada Eubiotics Market by Form
8.1.5.2.4 Canada Eubiotics Market by End-use
8.1.5.3 Mexico Eubiotics Market
8.1.5.3.1 Mexico Eubiotics Market by Product
8.1.5.3.2 Mexico Eubiotics Market by Application
8.1.5.3.3 Mexico Eubiotics Market by Form
8.1.5.3.4 Mexico Eubiotics Market by End-use
8.1.5.4 Rest of North America Eubiotics Market
8.1.5.4.1 Rest of North America Eubiotics Market by Product
8.1.5.4.2 Rest of North America Eubiotics Market by Application
8.1.5.4.3 Rest of North America Eubiotics Market by Form
8.1.5.4.4 Rest of North America Eubiotics Market by End-use
8.2 Europe Eubiotics Market
8.2.1 Europe Eubiotics Market by Product
8.2.1.1 Europe Probiotics Market by Country
8.2.1.2 Europe Organic Acids Market by Country
8.2.1.3 Europe Phytogenic Market by Country
8.2.1.4 Europe Prebiotics Market by Country
8.2.1.5 Europe Enzymes Market by Country
8.2.2 Europe Eubiotics Market by Application
8.2.2.1 Europe Gut Health Market by Country
8.2.2.2 Europe Immunity Market by Country
8.2.2.3 Europe Yield Market by Country
8.2.2.4 Europe Others Market by Country
8.2.3 Europe Eubiotics Market by Form
8.2.3.1 Europe Solid Market by Country
8.2.3.2 Europe Liquid Market by Country
8.2.4 Europe Eubiotics Market by End-use
8.2.4.1 Europe Poultry Feed Market by Country
8.2.4.2 Europe Swine Feed Market by Country
8.2.4.3 Europe Cattle Feed Market by Country
8.2.4.4 Europe Aquatic Feed Market by Country
8.2.4.5 Europe Others Market by Country
8.2.5 Europe Eubiotics Market by Country
8.2.5.1 Germany Eubiotics Market
8.2.5.1.1 Germany Eubiotics Market by Product
8.2.5.1.2 Germany Eubiotics Market by Application
8.2.5.1.3 Germany Eubiotics Market by Form
8.2.5.1.4 Germany Eubiotics Market by End-use
8.2.5.2 UK Eubiotics Market
8.2.5.2.1 UK Eubiotics Market by Product
8.2.5.2.2 UK Eubiotics Market by Application
8.2.5.2.3 UK Eubiotics Market by Form
8.2.5.2.4 UK Eubiotics Market by End-use
8.2.5.3 France Eubiotics Market
8.2.5.3.1 France Eubiotics Market by Product
8.2.5.3.2 France Eubiotics Market by Application
8.2.5.3.3 France Eubiotics Market by Form
8.2.5.3.4 France Eubiotics Market by End-use
8.2.5.4 Russia Eubiotics Market
8.2.5.4.1 Russia Eubiotics Market by Product
8.2.5.4.2 Russia Eubiotics Market by Application
8.2.5.4.3 Russia Eubiotics Market by Form
8.2.5.4.4 Russia Eubiotics Market by End-use
8.2.5.5 Spain Eubiotics Market
8.2.5.5.1 Spain Eubiotics Market by Product
8.2.5.5.2 Spain Eubiotics Market by Application
8.2.5.5.3 Spain Eubiotics Market by Form
8.2.5.5.4 Spain Eubiotics Market by End-use
8.2.5.6 Italy Eubiotics Market
8.2.5.6.1 Italy Eubiotics Market by Product
8.2.5.6.2 Italy Eubiotics Market by Application
8.2.5.6.3 Italy Eubiotics Market by Form
8.2.5.6.4 Italy Eubiotics Market by End-use
8.2.5.7 Rest of Europe Eubiotics Market
8.2.5.7.1 Rest of Europe Eubiotics Market by Product
8.2.5.7.2 Rest of Europe Eubiotics Market by Application
8.2.5.7.3 Rest of Europe Eubiotics Market by Form
8.2.5.7.4 Rest of Europe Eubiotics Market by End-use
8.3 Asia Pacific Eubiotics Market
8.3.1 Asia Pacific Eubiotics Market by Product
8.3.1.1 Asia Pacific Probiotics Market by Country
8.3.1.2 Asia Pacific Organic Acids Market by Country
8.3.1.3 Asia Pacific Phytogenic Market by Country
8.3.1.4 Asia Pacific Prebiotics Market by Country
8.3.1.5 Asia Pacific Enzymes Market by Country
8.3.2 Asia Pacific Eubiotics Market by Application
8.3.2.1 Asia Pacific Gut Health Market by Country
8.3.2.2 Asia Pacific Immunity Market by Country
8.3.2.3 Asia Pacific Yield Market by Country
8.3.2.4 Asia Pacific Others Market by Country
8.3.3 Asia Pacific Eubiotics Market by Form
8.3.3.1 Asia Pacific Solid Market by Country
8.3.3.2 Asia Pacific Liquid Market by Country
8.3.4 Asia Pacific Eubiotics Market by End-use
8.3.4.1 Asia Pacific Poultry Feed Market by Country
8.3.4.2 Asia Pacific Swine Feed Market by Country
8.3.4.3 Asia Pacific Cattle Feed Market by Country
8.3.4.4 Asia Pacific Aquatic Feed Market by Country
8.3.4.5 Asia Pacific Others Market by Country
8.3.5 Asia Pacific Eubiotics Market by Country
8.3.5.1 China Eubiotics Market
8.3.5.1.1 China Eubiotics Market by Product
8.3.5.1.2 China Eubiotics Market by Application
8.3.5.1.3 China Eubiotics Market by Form
8.3.5.1.4 China Eubiotics Market by End-use
8.3.5.2 Japan Eubiotics Market
8.3.5.2.1 Japan Eubiotics Market by Product
8.3.5.2.2 Japan Eubiotics Market by Application
8.3.5.2.3 Japan Eubiotics Market by Form
8.3.5.2.4 Japan Eubiotics Market by End-use
8.3.5.3 India Eubiotics Market
8.3.5.3.1 India Eubiotics Market by Product
8.3.5.3.2 India Eubiotics Market by Application
8.3.5.3.3 India Eubiotics Market by Form
8.3.5.3.4 India Eubiotics Market by End-use
8.3.5.4 Australia Eubiotics Market
8.3.5.4.1 Australia Eubiotics Market by Product
8.3.5.4.2 Australia Eubiotics Market by Application
8.3.5.4.3 Australia Eubiotics Market by Form
8.3.5.4.4 Australia Eubiotics Market by End-use
8.3.5.5 South Korea Eubiotics Market
8.3.5.5.1 South Korea Eubiotics Market by Product
8.3.5.5.2 South Korea Eubiotics Market by Application
8.3.5.5.3 South Korea Eubiotics Market by Form
8.3.5.5.4 South Korea Eubiotics Market by End-use
8.3.5.6 Malaysia Eubiotics Market
8.3.5.6.1 Malaysia Eubiotics Market by Product
8.3.5.6.2 Malaysia Eubiotics Market by Application
8.3.5.6.3 Malaysia Eubiotics Market by Form
8.3.5.6.4 Malaysia Eubiotics Market by End-use
8.3.5.7 Rest of Asia Pacific Eubiotics Market
8.3.5.7.1 Rest of Asia Pacific Eubiotics Market by Product
8.3.5.7.2 Rest of Asia Pacific Eubiotics Market by Application
8.3.5.7.3 Rest of Asia Pacific Eubiotics Market by Form
8.3.5.7.4 Rest of Asia Pacific Eubiotics Market by End-use
8.4 LAMEA Eubiotics Market
8.4.1 LAMEA Eubiotics Market by Product
8.4.1.1 LAMEA Probiotics Market by Country
8.4.1.2 LAMEA Organic Acids Market by Country
8.4.1.3 LAMEA Phytogenic Market by Country
8.4.1.4 LAMEA Prebiotics Market by Country
8.4.1.5 LAMEA Enzymes Market by Country
8.4.2 LAMEA Eubiotics Market by Application
8.4.2.1 LAMEA Gut Health Market by Country
8.4.2.2 LAMEA Immunity Market by Country
8.4.2.3 LAMEA Yield Market by Country
8.4.2.4 LAMEA Others Market by Country
8.4.3 LAMEA Eubiotics Market by Form
8.4.3.1 LAMEA Solid Market by Country
8.4.3.2 LAMEA Liquid Market by Country
8.4.4 LAMEA Eubiotics Market by End-use
8.4.4.1 LAMEA Poultry Feed Market by Country
8.4.4.2 LAMEA Swine Feed Market by Country
8.4.4.3 LAMEA Cattle Feed Market by Country
8.4.4.4 LAMEA Aquatic Feed Market by Country
8.4.4.5 LAMEA Others Market by Country
8.4.5 LAMEA Eubiotics Market by Country
8.4.5.1 Brazil Eubiotics Market
8.4.5.1.1 Brazil Eubiotics Market by Product
8.4.5.1.2 Brazil Eubiotics Market by Application
8.4.5.1.3 Brazil Eubiotics Market by Form
8.4.5.1.4 Brazil Eubiotics Market by End-use
8.4.5.2 Argentina Eubiotics Market
8.4.5.2.1 Argentina Eubiotics Market by Product
8.4.5.2.2 Argentina Eubiotics Market by Application
8.4.5.2.3 Argentina Eubiotics Market by Form
8.4.5.2.4 Argentina Eubiotics Market by End-use
8.4.5.3 Egypt Eubiotics Market
8.4.5.3.1 Egypt Eubiotics Market by Product
8.4.5.3.2 Egypt Eubiotics Market by Application
8.4.5.3.3 Egypt Eubiotics Market by Form
8.4.5.3.4 Egypt Eubiotics Market by End-use
8.4.5.4 Tanzania Eubiotics Market
8.4.5.4.1 Tanzania Eubiotics Market by Product
8.4.5.4.2 Tanzania Eubiotics Market by Application
8.4.5.4.3 Tanzania Eubiotics Market by Form
8.4.5.4.4 Tanzania Eubiotics Market by End-use
8.4.5.5 South Africa Eubiotics Market
8.4.5.5.1 South Africa Eubiotics Market by Product
8.4.5.5.2 South Africa Eubiotics Market by Application
8.4.5.5.3 South Africa Eubiotics Market by Form
8.4.5.5.4 South Africa Eubiotics Market by End-use
8.4.5.6 Nigeria Eubiotics Market
8.4.5.6.1 Nigeria Eubiotics Market by Product
8.4.5.6.2 Nigeria Eubiotics Market by Application
8.4.5.6.3 Nigeria Eubiotics Market by Form
8.4.5.6.4 Nigeria Eubiotics Market by End-use
8.4.5.7 Rest of LAMEA Eubiotics Market
8.4.5.7.1 Rest of LAMEA Eubiotics Market by Product
8.4.5.7.2 Rest of LAMEA Eubiotics Market by Application
8.4.5.7.3 Rest of LAMEA Eubiotics Market by Form
8.4.5.7.4 Rest of LAMEA Eubiotics Market by End-use
Chapter 9. Company Profiles
9.1 Koninklijke DSM N.V.
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Segmental and Regional Analysis
9.1.4 Research & Development Expense
9.1.5 Recent strategies and developments:
9.1.5.1 Partnerships, Collaborations, and Agreements:
9.1.5.2 Acquisitions and Mergers:
9.1.5.3 Product Launches and Product Expansions:
9.2 Novozymes A/S
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental and Regional Analysis
9.2.4 Research & Development Expense
9.3 BASF SE
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Segmental and Regional Analysis
9.3.4 Research & Development Expense
9.3.5 Recent strategies and developments:
9.3.5.1 Partnerships, Collaborations, and Agreements:
9.4 DuPont de Nemours, Inc.
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Segmental and Regional Analysis
9.4.4 Research & Development Expense
9.5 Chr. Hansen Holding A/S
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Segmental and Regional Analysis
9.5.4 Research & Development Expense
9.6 Lallemand, Inc.
9.6.1 Company Overview
9.6.2 Recent strategies and developments:
9.6.2.1 Partnerships, Collaborations, and Agreements:
9.7 Lesaffre Group
9.7.1 Company Overview
9.7.2 Recent strategies and developments:
9.7.2.1 Partnerships, Collaborations, and Agreements:
9.8 Kemin Industries, Inc.
9.8.1 Company Overview
9.8.2 Recent strategies and developments:
9.8.2.1 Product Launches and Product Expansions:
9.9 Cargill Corporation
9.9.1 Company Overview
9.9.2 Recent strategies and developments:
9.9.2.1 Product Launches and Product Expansions:
9.10. Calpis Co., Ltd. (Asahi Group Holdings, Ltd.)
9.10.1 Company Overview
9.10.2 Financial Analysis
9.10.3 Segmental Analysis
9.10.4 Recent strategies and developments:
9.10.4.1 Approvals and Trials:

Companies Mentioned

  • Koninklijke DSM N.V.
  • Novozymes A/S
  • BASF SE
  • DuPont de Nemours, Inc.
  • Chr. Hansen holding A/S
  • Lallemand, Inc.
  • Lesaffre Group
  • Kemin Industries, Inc.
  • Cargill Corporation
  • Calpis Co., Ltd.

Methodology

Loading
LOADING...

Table Information